Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in Physiology and Pathology

Frontiers in Neuroanatomy - Switzerland
doi 10.3389/fnana.2016.00044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Ceftriaxone Ameliorates Tau Pathology and Cognitive Decline via Restoration of Glial Glutamate Transporter in a Mouse Model of Alzheimer's Disease

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2015English

Tau Pathology in Parkinson's Disease

Frontiers in Neurology
Neurology
2018English

Chronic Nicotine Administration Exacerbates Tau Pathology in a Transgenic Model of Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2009English

Alzheimer's Disease, Delusions and Cognitive Decline

Acta Neuropsychiatrica
PsychiatryMental HealthBiological Psychiatry
2006English

Targeting Aβ and Tau in Alzheimer's Disease, an Early Interim Report

Experimental Neurology
Developmental NeuroscienceNeurology
2010English

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

High-Contrast In-Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies

2020English

Human P301l-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy